Patent · US Active

Combination therapies for treating cancers

US12076399B2 · kind B2 · utility

0Cited by

13References

9Claims

0Family size

Assignee

Cothera Bioscience, Inc. · KY

Inventors

Yihong Zhang · Madison, US
Wang Wei · 流花街道, CN
Yiyou Chen · Beijing, CN

Key dates

Filing date	Jun 1, 2018
Grant date	Sep 3, 2024
Priority date	—
Expiry date	Feb 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are combination therapies and related compositions and methods for treating cancers, including epithelial tumors, which include a combination of at least two agents such as an epidermal growth factor receptor (EGFR) inhibitor, a mitogen-activated protein kinase (MEK) 1/2 inhibitor; and a cyclin dependent kinase (CDK) 4/6 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.